Computer Aided Detection Market: Snapshot
The global computer aided detection (CAD) market is in its early stages of growth and is increasingly reliant on the market dynamics of corresponding imaging modalities for market penetration. The growing usage of CAD software solutions for a number of diagnostic applications such as cardiovascular, oncology, musculoskeletal, and neurological has made the market highly specific, dynamic, and competitive with significant growth potential. The revenue generated by the global CAD market was pegged at US$437 mn in 2015 and is anticipated to cross US$1 bn by 2024. The market is expected to expand at a strong CAGR of 9.8% from 2016 to 2024.
Computer Aided Detection Most Widely Used in Breast Cancer Screening
Computer aided detection technology finds application mainly in oncology and cardiovascular and neurological indications. Breast cancer was the leading application segment of the market in 2015 and is projected to sustain its position during the forecast period. Its dominance can be attributed to the increasing number of breast cancer detection applications and a lower risk of observational errors by using CAD solutions in combination with mammography. Favorable reimbursement scenario for breast cancer CAD solutions in developed nations and its well-established identity as a supplement tool in the diagnosis of breast cancer also contribute to the growth of the segment. The prostate cancer application segment is projected to expand at the fastest growth rate from 2016 to 2024. This can be attributed to the increasing number of regulatory approvals for various prostate cancer detection CAD solutions and the rising incidence of the disease.
Growing Incidence and Prevalence of Breast Cancer in U.S. Driving North America Market
Geographically, the computer aided detection market has been segmented into five major regions: North America, Latin America, Asia Pacific, Europe, and the Middle East and Africa. North America held the leading share in the global computer aided detection market in terms of revenue in 2015, followed by Europe. The dominance of these two regions is owing to the rising incidence and prevalence of breast cancer, the growing awareness level about early screening of breast cancer, an increase in the geriatric population, and rapid advancement in various healthcare technologies. The U.S. forms the most significant market for computer aided detection in North America as well as globally as it is an important innovation hub and leading companies in the segment have been conducting thorough research and development. Moreover, the World Cancer Research Fund (WCRF) statistics show that North America reported the highest number of new breast cancer cases in 2012, with around 226,125 in the U.S. alone. This also acts as a growth driver for the computer aided detection market in the region.
Asia Pacific is also a prominent market for computer aided detection. The region accounts for over 60% of the world’s population, which translates to a significant patient pool and large number of imaging procedures. According to the Asian Pacific Journal of Cancer Prevention (2010), there were over 3 million new cancer cases and over 2 million cancer deaths in Asia. Projections suggest the number of new cancer cases in Asia will increase to 7.1 million by 2020 if existing prevention and management strategies remain unchanged. However, most of the countries in the region are positioning themselves as medical tourism destinations for developed nations. This will encourage healthcare providers to adopt advanced computer aided detection in imaging technologies.
Key players in the computer aided detection market include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.
Computer aided detection (CAD) is a clinically established tool that helps in the diagnosis or detection of cancers, and cardiovascular and neurological diseases. These systems assist physicians to decrease false negative rate, detect cancer at early stages, reduce mortality rates caused due to cancer and other diseases, and improve inter and intra reader variability. Additionally, CAD systems are extensively used to help physicians in numerous tasks that include providing a second opinion to the diagnostic and detection outcomes and automatically recognizing all non-calcified lesions doubted of malignancy at images. A CAD system helps in diagnosis, detection, and risk assessment. The purpose of using a computer and CAD tools is to help in medical image diagnosis. Technologically advanced CAD systems provide a moderately trained physician the same diagnostic skills as an experienced radiologist. CAD has also been used to increase the sensitivity of diagnostic imaging in medical investigation and differential diagnostics.
This research study analyzes the market for computer aided detection in terms of revenue (US$ Mn). The market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. The report also includes key market dynamics, such as drivers, restraints, and opportunities, affecting the demand for computer aided detection products globally and country wise. Comparative analysis has also been included in the executive summary for each region of 2016 and 2024.
The report provides in-depth analysis of the computer aided detection market. The stakeholders of this report include companies engaged in the manufacture of CAD products used along with medical imaging equipment in screening of cancers and other diseases. The executive summary section is included in this report to provide a snapshot of the market. It summarizes the market size, trends, and competition in different regions.
The market overview section of this report analyzes market dynamics such as drivers, restraints, and opportunities that influence the computer aided detection market in the current and future scenario. Market share analysis is provided to signify percentage share of the major players operating in the computer aided detection market. These factors will help the market players to chalk out business strategies and plans to strengthen their positions in the global market.
Based on application, the computer aided detection market has been segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, liver cancer, other cancers, and other disease. In terms of imaging modality, the market has been segmented into mammography, magnetic resonance imaging, ultrasound imaging, tomosynthesis, CT, and others.
In terms of region, the computer aided detection market has been segmented into four major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Moreover, analysis for the major countries such as the U.S., Canada, Germany, the U.K., Japan China, Russia, Brazil, Mexico, and South Africa have been provided in the report. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market in various regions has been provided in this section.
The report provides market estimation of the computer aided detection market in terms of revenue (US$ Mn) for all the segments and sub segments, with CAGR % for the period from 2016 to 2024, considering 2015 as the base year. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in the global market during the forecast period from 2016 to 2024.
This report also includes a recommendations section that will assist new companies to establish their presence and existing market players to expand their market shares in the computer aided detection market. The report concludes with the company profile section, which includes company overview, financial overview, product portfolio, business strategies, and recent developments of market players. Key players profiled in the report include Agfa-Gevaert N.V., Fujifilm Medical Systems USA, Inc., GE Healthcare, Hitachi Medical Corporation, Hologic, Inc., Samsung Medison Co. Ltd, and Philips Healthcare.
The global computer aided detection market has been segmented as follows:
Computer Aided Detection Market, by Application
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Liver Cancer
- Bone Cancer
- Other Cancer
- Cardiovascular and Neurological Indications
Computer Aided Detection Market, by Imaging Modality
- Ultrasound Imaging
- Magnetic Resonance Imaging
- Computed Tomography
Computer Aided Detection Market, by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest Of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East & Africa
- South Africa
- Rest of Middle East & Africa